Azzeddine Charki | Neuropsychology | Best Researcher Award

Published on by Cognitive Scientist Awards

Assist. Prof. Dr. Azzeddine Charki | Neuropsychology | Best Researcher Award 

Dr. Azzeddine Charki is a Professor of Cognitive and Biological Psychology at the Faculty of Letters and Human Sciences Aïn Chock, Hassan II University, Casablanca. He holds a Ph.D. in Neuropsychology from Sidi Mohamed Ben Abdellah University, Fez. Dr. Charki is an esteemed researcher and active member of the Laboratory for Studies and Research in Cognitive and Human Sciences, focusing on psychology and language. With a strong dedication to cognitive psychology and neuropsychology, he supervises numerous research projects and contributes significantly to academic discourse. He has authored and co-authored several publications in high-impact journals on topics such as executive function, mentalizing, and neurodevelopmental disorders like ASD and ADHD. Fluent in Arabic, French, and English, he integrates pedagogical expertise with rigorous data analysis and project management. Dr. Charki’s commitment to advancing psychological science is matched by his passion for mentoring and fostering academic growth in his field.

Profile

🎓 Education

Dr. Azzeddine Charki earned his Ph.D. in Neuropsychology from Sidi Mohamed Ben Abdellah University, Fez. His doctoral work laid the foundation for his deep specialization in neuropsychology and cognitive sciences, particularly in executive function and mentalizing. Throughout his academic training, he developed a multidisciplinary understanding of brain-behavior relationships, integrating biological, cognitive, and social perspectives. His education emphasized both theoretical models and practical application in clinical and developmental contexts. Dr. Charki also received training in pedagogy, research methodology, and advanced data analysis techniques, which he continues to use in his academic career. His strong educational background has enabled him to contribute to Moroccan and international scholarship in cognitive and neuropsychology. His academic formation has also nurtured a strong inclination toward interdisciplinary research and collaborative knowledge production, particularly in the study of social cognition and neurodevelopmental disorders such as autism and ADHD.

🧪 Experience

Dr. Azzeddine Charki began his academic career as a Temporary Professor at Sidi Mohamed Ben Abdellah University, Fez (2020–2022), where he taught and conducted research in cognitive and neuropsychology. Since November 2023, he has been serving as Assistant Professor at the Faculty of Letters and Human Sciences Aïn Chock, Hassan II University, Casablanca. Over the years, he has supervised numerous undergraduate and postgraduate research projects and participated in collaborative initiatives within the university’s Laboratory for Studies and Research in Cognitive and Human Sciences. In addition to his teaching responsibilities, Dr. Charki has contributed extensively to the academic literature with a focus on executive functioning, theory of mind, and developmental psychopathology. His professional experience also includes project management, scientific writing, and dissemination of research findings. His bilingual and multicultural skills have allowed him to reach a wide range of students and researchers across Arabic, Francophone, and Anglophone academic contexts.

🏅 Awards and Honors

Dr. Azzeddine Charki has earned recognition primarily through his impactful research publications and academic service in Morocco’s leading institutions. Although specific named awards were not detailed, his repeated inclusion in peer-reviewed international and regional journals such as Applied Neuropsychology: Child, Neuropsychiatry and Neuropsychology, and the Arab Journal of Psychology signifies scholarly acknowledgment of his research excellence. His work on autism spectrum disorder, theory of mind, and executive functions reflects high intellectual merit and contributes meaningfully to both theoretical understanding and practical applications in neuropsychology. Dr. Charki’s mentorship of numerous student research projects and his active engagement in cross-disciplinary studies also underscore his standing as a respected academic. Being a core member of a cognitive science laboratory at Hassan II University further testifies to his leadership in scientific inquiry and academic collaboration. These contributions collectively demonstrate his respected status and growing impact in the field of cognitive psychology and neurodevelopmental research.

🔬 Research Focus

Dr. Charki’s research centers on cognitive psychology and neuropsychology, with particular interest in executive functions, social cognition, and neurodevelopmental disorders. He investigates mentalizing processes, especially the cognitive and affective domains of theory of mind in children with Autism Spectrum Disorder (ASD). His work explores both typical and atypical development, aiming to identify neural and behavioral mechanisms underlying disorders such as ASD and ADHD. He also delves into comparative frameworks across schizophrenia spectrum disorders, highlighting the neurobiological overlap in social cognition deficits. Dr. Charki integrates developmental psychology, neurobiology, and psychometric assessments to explore how children’s cognitive representations are structured and evolve in different socio-cultural contexts. His scholarly publications demonstrate a strong methodological foundation and innovative contributions to understanding how executive functions interact with social behavior. Furthermore, he actively examines Moroccan sociocultural representations in educational contexts, blending qualitative and quantitative approaches to enrich cognitive psychological theory and practice.

✅ Conclusion

Dr. Azzeddine Charki is a dedicated cognitive psychologist whose interdisciplinary research on executive function, mentalizing, and neurodevelopmental disorders enhances both scientific understanding and educational practice through a culturally grounded and evidence-based approach.

Publications

  • Charki, A., Zarbouch, B., Bouchala, C., & Meklaui, F., Z . (2024). Neuronal and developmental dimensions of mentalizing and it’s connection with executive functions. Arab Journal of Psychology. https://doi.org/10.57642/AJOPSY911

 

  • Charki, A., Meklaoui, F. Z., Charki, A., & Ettouzani, A. (2025). Examining the association between variation of ASD and cognitive and affective domains of mentalizing in verbal children with ASD. Applied Neuropsychology: Child, 1–11. https://doi.org/10.1080/21622965.2025.2504502

 

 

 

 

 

 

Melania Ruggiero | Neuroinflammation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Melania Ruggiero | Neuroinflammation | Best Researcher Award

Dr. Melania Ruggiero is a postdoctoral researcher at the University of Bari Aldo Moro, specializing in neuroinflammation and neurodegenerative diseases. She earned her Master’s degree in Medical Biotechnology and Nanobiotechnology from the University of Salento in 2020, followed by a PhD in Functional and Applied Genomics and Proteomics from the University of Bari Aldo Moro in 2024. Throughout her academic journey, she has attended specialized training in neuroscience and advanced fluorescence microscopy. Her research focuses on exploring bioactive compounds for neuroprotection, reprogramming astrocytes into neurons, and mitigating neuroinflammatory processes. She has contributed extensively to scientific literature, authoring multiple publications in high-impact journals, and currently serves as a reviewer for journals such as the International Journal of Molecular Sciences and Cells. Dr. Ruggiero actively collaborates with national and international research groups, contributing to innovative approaches in the treatment of neurodegenerative disorders.

Profile

🎓 Education

Dr. Melania Ruggiero’s academic journey began with her Master’s degree in Medical Biotechnology and Nanobiotechnology at the University of Salento (2020), where she gained a strong foundation in molecular biology, biotechnology, and nanomedicine. She subsequently pursued a PhD in Functional and Applied Genomics and Proteomics at the University of Bari Aldo Moro (2024), during which she engaged in extensive research focused on neurodegenerative disorders. Her doctoral studies were enriched by attending specialized courses, including the “Cellular, Behavioural and Cognitive Neuroscience” school and the “Fluomicro@ICGEB-ICGEB Practical Course of Fluorescence Microscopy and High Throughput Imaging.” These programs equipped her with advanced skills in cellular neuroscience, imaging, and data analysis. Her academic training provided a strong interdisciplinary foundation that bridges biotechnology, neuroscience, and clinical research, supporting her ongoing contributions to innovative treatments for neurodegenerative diseases.

🧪 Experience

Dr. Ruggiero’s professional experience encompasses advanced academic research and international collaboration. Currently a postdoctoral researcher at the Department of Biosciences, Biotechnology and Environment at the University of Bari Aldo Moro, she actively investigates neurodegeneration, neuroinflammation, and potential therapeutic interventions. Her research has led to seven completed and five ongoing research projects. Dr. Ruggiero’s expertise includes the study of bioactive compounds for neuroprotection, demonstrating their ability to reduce neuroinflammatory processes and promote astrocyte reprogramming. She has authored numerous peer-reviewed publications and is actively involved in peer-review activities for journals such as International Journal of Molecular Sciences and Cells. Her collaborative network extends across various esteemed institutions, including universities in Italy and Saudi Arabia. Dr. Ruggiero’s experience reflects a commitment to cutting-edge neuroscience research, fostering translational approaches to combat neurodegenerative disorders.

🏅 Awards and Honors

While specific awards are not listed, Dr. Ruggiero’s scholarly contributions demonstrate substantial recognition in the scientific community. Her numerous publications in internationally indexed journals, with a current h-index of 6, signify her growing influence and impact in the field of neuroscience. Serving as a peer reviewer for prestigious journals such as International Journal of Molecular Sciences and Cells highlights her standing as a respected expert. Additionally, her collaborations with multiple international institutions reflect her role as a valued scientific partner in global research networks. Her research findings, particularly on the neuroprotective roles of bioactive compounds and astrocyte reprogramming, position her as a strong candidate for the Best Researcher Award, acknowledging her innovative contributions to neuroscience and neurodegenerative disease research.

🔬 Research Focus

Dr. Ruggiero’s research centers on neuroinflammation and neurodegenerative diseases, with a particular emphasis on bioactive compounds as potential therapeutic agents. Her innovative work has demonstrated that compounds such as resveratrol, vitamin C, irisin, and lactoferrin can reduce astrogliosis and microgliosis, mitigating neuroinflammatory responses that underlie neurodegeneration. Significantly, she has pioneered findings showing that lactoferrin not only attenuates astrocyte reactivity but also reprograms astrocytes into neuronal precursor cells, promoting neurogenesis and counteracting neuronal loss. This groundbreaking research contributes to developing safer, more effective therapies for neurodegenerative disorders, minimizing side effects compared to conventional treatments. Her work integrates cellular biology, molecular neuroscience, and translational medicine, advancing novel therapeutic strategies for conditions such as Alzheimer’s and Parkinson’s disease. Her collaborations across national and international institutions further enhance the multidisciplinary nature and clinical relevance of her research.

✅ Conclusion

Dr. Melania Ruggiero is an emerging leader in neurodegenerative research, whose pioneering work on bioactive compounds and astrocyte reprogramming offers innovative therapeutic avenues, demonstrated through extensive publications, international collaborations, and impactful scientific contributions, making her a strong candidate for the Best Researcher Award.

Publications

Aymane Edder | Ai and Iot in Healthcare | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr. Aymane Edder | Ai and Iot in Healthcare | Best Researcher Award

Edder Aymane is a highly motivated third-year PhD student specializing in Tiny Machine Learning (TinyML) for vital signs monitoring. Based in Casablanca, Morocco, his research focuses on developing efficient machine learning models deployable on embedded systems to analyze and interpret biomedical data in real-time, ultimately enhancing health monitoring and diagnostics. His technical expertise spans TinyML, embedded systems, IoT, biomedical signal processing, model optimization, and programming languages such as Python, C/C++, and MATLAB. Edder has gained hands-on experience through internships at ERAMEDIC, CHU Ibn Rochd, MEDICINA, and BRET LAB, contributing to various healthcare technology projects including the development of remote monitoring prototypes for COVID-19 patients. His academic journey reflects a strong foundation in biomedical engineering, industrial science physics, and medical analysis, complemented by extensive practical skills. Fluent in Arabic and English, with intermediate proficiency in French, Edder Aymane is committed to advancing real-time healthcare solutions through innovative machine learning applications.

Profile

🎓 Education

Edder Aymane’s educational path demonstrates a strong interdisciplinary foundation. He is currently pursuing his PhD at UM6SS, Casablanca (2023–present), focusing on TinyML applications for healthcare monitoring. He earned his Engineering Degree in Biomedical Sciences from ENSAM Rabat (2019–2022), where he worked on practical projects such as remote vital parameters monitoring for COVID-19 patients. Prior to that, he completed preparatory classes in Industrial Science Physics (PSI) (2017–2019), which equipped him with a strong base in physics and engineering principles. Throughout his academic training, Edder engaged in various internships at leading healthcare and research institutions, including ERAMEDIC, CHU Ibn Rochd, and MEDICINA, where he gained real-world experience in laboratory analysis, medical device installation, and healthcare informatics. His academic career combines theoretical learning with hands-on practice, positioning him well for advanced research in biomedical machine learning and embedded systems.

🧪 Experience

Edder Aymane has developed extensive professional experience through diverse internships and research projects related to healthcare technology and biomedical engineering. At ERAMEDIC (July–Sept 2021), he contributed to the installation of Neuro-Navigation Surgery Software and pre-installation of radiology rooms. During his time at MEDICINA (July–Aug 2020), he performed internal and external quality control of biochemistry, hematology, and serology automat systems. At CHU Ibn Rochd, he was involved in setting up COVID-19 services and developing remote monitoring prototypes for vital signs during the pandemic. His end-of-studies internship at BRET LAB (2023–present) further strengthened his research expertise in biomedical signal processing and TinyML model development. These experiences allowed him to apply his technical skills in embedded systems, IoT integration, and machine learning, giving him a well-rounded profile in both research and applied biomedical technologies.

🏅 Awards and Honors

While specific formal awards and honors are not listed, Edder Aymane’s consistent selection for highly technical internships and research projects at reputable healthcare institutions demonstrates recognition of his expertise and potential. His involvement in cutting-edge projects such as the development of a prototype remote vital parameters monitor for COVID-19, installation of complex neuro-navigation systems, and leadership roles during his internships indicate a high level of trust from supervisors and collaborators. His acceptance into the PhD program at UM6SS to work on emerging fields like TinyML reflects both academic and professional acknowledgment of his abilities. Additionally, his multidisciplinary skillset in machine learning, embedded systems, and biomedical signal processing showcases his outstanding technical competency, positioning him as a promising researcher poised for future honors as his academic career progresses.

🔬 Research Focus

Edder Aymane’s research focuses on leveraging Tiny Machine Learning (TinyML) for real-time health monitoring and diagnostics. His work involves developing highly efficient machine learning models optimized for deployment on embedded systems with limited computational resources. Specifically, he focuses on analyzing biomedical signals such as ECG data, enabling continuous monitoring of vital signs directly from wearable or portable devices. His research integrates advanced signal processing techniques, noise filtering, IoT protocols (MQTT, CoAP, BLE), and real-time data interpretation, contributing to more accessible, scalable healthcare solutions. By combining biomedical engineering with embedded AI, Edder aims to bridge the gap between sophisticated machine learning models and practical, low-power medical devices. His work has significant implications for early diagnostics, remote patient monitoring, and scalable healthcare delivery, particularly in resource-limited settings. This research contributes to the growing field of personalized, preventive healthcare powered by intelligent, real-time monitoring systems.

✅ Conclusion

Edder Aymane is an emerging biomedical researcher specializing in TinyML for vital signs monitoring, with a strong foundation in biomedical engineering, embedded systems, IoT, and machine learning; his hands-on experience across leading healthcare institutions and advanced research in real-time healthcare monitoring position him as a promising innovator poised to advance scalable, efficient, and accessible healthcare solutions through cutting-edge embedded AI technologies.

Publications

Ahmad Muhammad | Medical Image Analysis | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr. Ahmad Muhammad | Medical Image Analysis | Best Researcher Award

Muhammad Ahmad is a passionate AI researcher and software engineer currently pursuing a Master’s in Information and Communication Engineering at the University of Electronic Science and Technology of China (UESTC). With a Bachelor’s in Computer Science from the University of South Asia, Lahore, he has gained extensive experience in generative AI, LLMs, deep learning, and medical image analysis. He has served as a Software Engineer at E-teleQuote Inc. (USA), where he led projects involving LLaMA 3.1, sentiment analysis, and real-time chatbot systems. His academic contributions include first-author publications on Alzheimer’s disease and brain tumor diagnosis using hybrid deep learning models. Recognized with multiple awards and scholarships, including a fully funded Master’s scholarship, Ahmad brings together strong programming skills, leadership experience, and a commitment to innovation in healthcare AI. His work reflects a deep interest in combining machine learning with medical imaging to solve real-world challenges through intelligent systems.

Profile

🎓 Education

Muhammad Ahmad holds a Master’s degree in Information and Communication Engineering from UESTC, Chengdu, China, where he maintains a GPA of 3.54/4.0 and focuses on generative AI, LLMs, deep learning, and medical image analysis. Previously, he earned a BS in Computer Science from the University of South Asia, Lahore, Pakistan, graduating with a CGPA of 3.16/4.0. His final year project—Walmart Weekly Sales Prediction—reflected his early commitment to machine learning. His academic journey has been bolstered by self-motivated learning, with certifications from Stanford University, IBM, and DeepLearning.AI in TensorFlow, machine learning with Python, and data analysis. Alongside his formal education, Ahmad has organized machine learning workshops and led ACM and IEEE student chapters, showcasing a combination of technical proficiency and community leadership. His educational background lays a strong foundation for interdisciplinary AI research, especially in biomedical applications.

🧪 Experience

Muhammad Ahmad has valuable industry experience as a Software Engineer in AI at E-teleQuote Inc. (Florida, USA), where he led projects utilizing LLaMA 3.1 for document processing and chatbot development. He developed robust NLP solutions, including sentiment analysis and speech recognition systems, while deploying and optimizing AI models for production environments. Earlier, during his internship at Quid Sol (Lahore), he worked on deep learning-based object detection, segmentation, and noise reduction, applying feature engineering and model optimization techniques. Beyond technical roles, he held leadership positions, including Vice-Chair of the ACM Society and event organizer for IEEE, fostering innovation within academic communities. Ahmad’s experience combines hands-on coding with strategic project leadership in AI, making him adept at translating theoretical machine learning concepts into real-world applications, particularly in healthcare and image analysis domains.

🏅 Awards and Honors

Muhammad Ahmad’s academic excellence and leadership have earned him multiple awards. He received a fully funded scholarship from the University of Electronic Science and Technology of China (UESTC) to pursue his Master’s studies in AI. In 2020, he was awarded a semester scholarship for conducting a high-impact workshop on machine learning at the University of South Asia. His community engagement was recognized by the Rooh Foundation and the Government of Pakistan for volunteer work with the Humanity Welfare Foundation. In technical competitions, he secured 1st place at COMSATS University’s Web Development Competition (April 2018) and 2nd place at Superior University (September 2018), demonstrating his early programming excellence. Additionally, Ahmad has earned respected certifications in machine learning, deep learning, and data analysis from Stanford, IBM, and CognitiveClass.ai, highlighting his continuous pursuit of technical mastery in the field of artificial intelligence and data science.

🔬 Research Focus

Muhammad Ahmad’s research focuses on deep learning, generative AI, and large language models (LLMs), particularly applied to medical image analysis. He is committed to enhancing diagnostic accuracy in complex medical conditions using AI. His notable work includes developing a hybrid deep learning architecture with adaptive feature fusion for multi-stage Alzheimer’s disease classification, published in Brain Sciences. Another study, submitted to the International Journal of Machine Learning and Cybernetics, proposes a dynamic fusion model for brain tumor diagnosis. His academic pursuits aim to integrate LLMs and computer vision for robust, intelligent medical systems. Ahmad’s goal is to bridge gaps between artificial intelligence and clinical practice, focusing on real-time, explainable, and scalable AI systems for healthcare. His research embodies a combination of theoretical rigor and practical implementation, striving to deliver solutions that are both impactful and clinically relevant.

✅ Conclusion

Muhammad Ahmad is a driven AI researcher and engineer specializing in generative AI, LLMs, and deep learning for medical imaging, with proven academic, research, and industry experience, recognized through prestigious awards and impactful publications, currently contributing to advanced healthcare technologies at UESTC

Publications

  • Hybrid Deep Learning Architecture with Adaptive Feature Fusion for Multi-Stage Alzheimer’s Disease Classification

    Brain Sciences
    2025-06-06 | Journal article
    DOI: 10.3390/brainsci15060612
    CONTRIBUTORS: Ahmad Muhammad; Qi Jin; Osman Elwasila; Yonis Gulzar
  • Dynamic Fusion of Local and Global Features for Superior Brain Tumor Diagnosis Submitted as First Author
    to International Journal of Machine Learning and Cybernetics. Submission ID: 6a1c905c-080c-44f9-98e8-
    4f23727a5dc7.

Marta Comes Carsí | Psychiatry and ophthalmology | Women Researcher Award

Published on by Cognitive Scientist Awards

Mrs. Marta Comes Carsí | Psychiatry and ophthalmology | Women Researcher Award

Hospital Clínico Universitario de Valencia, Spain

Mrs. Marta Comes Carsí is a Spanish ophthalmologist from Valencia with extensive clinical and academic expertise in visual sciences, retina, and ocular pathologies. Born on November 12, 1992, she currently serves as a Facultativo Especialista in Ophthalmology at the Hospital Clínico Universitario de Valencia. Her medical career is marked by specialized training across top hospitals in Spain, including Barcelona and Valencia, and advanced postgraduate studies in retina, uveitis, and clinical ophthalmology. With multiple master’s degrees and international certifications from the European Board of Ophthalmology and the International Council of Ophthalmology, Mrs. Comes Carsí combines a strong academic foundation with practical excellence. Her research explores structural and functional alterations of the retina, especially in psychiatric conditions, and has been published in prestigious ophthalmological journals. Fluent in English and Catalan, she actively contributes to continuing medical education and integrates evidence-based practices in clinical care.

Profile

🎓 Education

Mrs. Marta Comes Carsí obtained her medical degree from the Universitat de València in 2016, laying a strong foundation for her specialization in ophthalmology. She then completed a Master’s in Clinical Medicine at Universidad Camilo José Cela (2017), followed by multiple postgraduate degrees at Universidad Tecnológica de las Islas Canarias in Retina and Uveitis, Clinical Ophthalmology, and Ocular Pathologies (2024). She earned the European Board of Ophthalmology Diploma (EBO) and multiple certifications from the International Council of Ophthalmology (ICO) in Clinical Ophthalmology, Visual Sciences, and Optics. Her extensive additional training includes accredited university courses in surgical techniques, pediatric glaucoma, corneal diseases, and ocular inflammation. This multidisciplinary academic background equips her with the knowledge to manage complex ocular conditions and to contribute significantly to academic research and clinical teaching. Her education reflects a continuous commitment to staying updated with evolving practices and innovations in visual science and eye health.

🧪 Experience

Mrs. Marta Comes Carsí has accumulated a wide range of clinical experience through her progressive roles in leading Spanish medical institutions. She began her residency at Hospital Clínico y Provincial de Barcelona in 2017 and continued at the Hospital Clínico Universitario de Valencia from 2020 to 2024. Her dedication and expertise earned her a permanent position as a Facultativo Especialista in Ophthalmology at the same Valencia hospital, where she now works part-time. Mrs. Comes Carsí’s clinical work spans general ophthalmology, retinal pathologies, anterior segment imaging, and pediatric ocular disorders. Her experience also includes performing ophthalmologic surgeries and diagnosing complex visual system disorders. She actively participates in scientific and academic programs, blending patient care with educational involvement. Her clinical background, enriched with hands-on training and high-level certifications, reflects a comprehensive and evolving practice in visual health, making her a reliable clinician, researcher, and educator in the field of ophthalmology.

🏅 Awards and Honors

Mrs. Marta Comes Carsí’s commitment to academic and clinical excellence has been recognized through several prestigious achievements. She was awarded the European Board of Ophthalmology (EBO) Diploma in 2024, a significant credential demonstrating her advanced expertise across European standards. Additionally, she earned certifications from the International Council of Ophthalmology in Clinical Ophthalmology, Visual Sciences, and Optics—honors that underscore her global standing in ophthalmic education. Her dedication to continuing education is evident in her completion of specialized university-accredited courses in glaucoma, surgical ophthalmology, corneal diseases, and pediatric pathologies. These honors signify her commitment to lifelong learning and delivering the highest standards of care in ophthalmology. Her active involvement in continuing education programs and international evaluations confirms her drive for excellence and positions her as a highly respected ophthalmologist committed to best practices, academic advancement, and patient-centered care.

🔬 Research Focus

Mrs. Marta Comes Carsí’s research primarily focuses on the intersection of ophthalmology and systemic or neuropsychiatric conditions, particularly studying structural and functional retinal changes. Her recent work includes investigations into visual function and retinal morphology in patients with bipolar disorder, indicating a multidisciplinary approach that integrates psychiatry and ophthalmology. She also contributes to anterior segment imaging studies, such as iris abnormalities using optical coherence tomography (OCT). Her publications, appearing in Archivos de la Sociedad Española de Oftalmología, highlight her emphasis on evidence-based clinical advancements. Mrs. Comes Carsí applies her research findings to refine diagnostic accuracy and therapeutic approaches in complex ocular pathologies. Her focus on retinal diagnostics and systemic ocular manifestations supports the advancement of personalized ophthalmic care. By combining advanced imaging, clinical insight, and inter-disciplinary research, she is contributing to a broader understanding of ocular biomarkers relevant to both ophthalmology and systemic disease diagnosis.

✅ Conclusion

Mrs. Marta Comes Carsí exemplifies the integration of clinical expertise, academic rigor, and research innovation in modern ophthalmology. With a solid educational foundation, diverse hospital experience, and internationally recognized certifications, she advances patient care while contributing to scientific understanding of ocular diseases. Her work stands at the forefront of visual science and clinical excellence.

Publications

  • Marta Comes Carsí; Delia Hernández Pérez; Antonio Miguel Duch Samper. Subretinal hemorrhages
    with subfoveal involvement after blunt ocular trauma, in a patient with pseudoxanthoma elasticum and
    angioid streaks. Archivos de la Sociedad Española de Oftalmología (English Edition). 99 – 9, pp. 412.
    Elsevier BV, 22/06/2024. DOI: 10.1016/j.oftale.2024.05.013. Epub 2024 Jun 22.>. ISSN 2173-5794

  • Marta Comes Carsí; Noemí Ruiz Del Río; Antonio Miguel Duch Samper. Myopic macular pit with
    scleral dehiscence in highly myopic patient. Archivos de la Sociedad Española de Oftalmología
    (English Edition). Elsevier BV, 20/07/2024. DOI: 10.1016/j.oftale.2024.07.008>. ISSN 2173-5794
  • Marta Comes Carsí; Elena Gracia Rovira; Laura Manfreda Domínguez; Vicente Tomás Pérez
    Torregrosa; John Paul Liscombe Sepúlveda; Antonio Miguel Duch Samper. Oclusión combinada de
    vena central de la retina y arteria ciliorretiniana en dos pacientes jóvenes. Archivos de la Sociedad
    Espanola de Oftalmologia. Elsevier BV, 19/08/2024. https://doi.org/10.1016/j.oftal.2024.08.006.>.
    ISSN 0365-6691
  • Noemí Ruiz Del Río; Marta Comes Carsí; Leyre Sanz Gallen. Roséola sifilítica iridiana. Utilidad de la
    tomografía de coherencia óptica de segmento anterior. Archivos de la Sociedad Espanola de
    Oftalmologia. Elsevier BV, 24/08/2024. https://doi.org/10.1016/j.oftal.2024.08.004>. ISSN 0365-6691
  • Marta Comes Carsi; José Miguel Vilaplana Mora; Laura Manfreda Domínguez; Carlos Cañete
    Nicolás; Antonio Miguel Duch Samper. Alteraciones en la función visual y en la estructura retiniana
    de los pacientes con trastorno bipolar. Archivos de la sociedad española de oftalmología. (España):
    elsevier, 05/2025. <https://doi.org/10.1016/j.oftal.2025.03.007>.
  • Marta Comes Carsí; Sergio Alfredo Maugard Tepper; Antonio Miguel Duch Samper. Mamilaciones
    de iris bilaterales. Imagen de tomografía de coherencia óptica del segmento anterior.ARCHIVOS DE
    LA sociedad española de oftalmología. 04/2025.<https://doi.org/10.1016/j.oftal.2024.11.005>.
  • Marta Comes Carsí; Sergio Alfredo MAUGARD TEPPER; Amparo Lanuza García; Antonio Miguel
    Duch Samper. Orbital abscess surgery in a patient with odontogenic pansinusitis. Acta
    ophthalmologica. 100 – S275, pp. 1755 -3768. John Wiley & Sons, 20/12/2022.
    https://doi.org/10.1111/j.1755-3768.2022.0267>. ISSN 1755-375X

 

Kadir Uludag | Educational Psychology | Educational Psychology Impact

Published on by Cognitive Scientist Awards

Dr. Kadir Uludag | Educational Psychology | Educational Psychology Impact

Dr. Kadir Uludag is a postdoctoral researcher in psychology with a Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences. His research bridges schizophrenia, brain imaging, and educational psychology. Dr. Uludag is passionate about disseminating scientific knowledge through his personal website (ifx0.com/psychology), YouTube channel (youtube.com/boooringlearning), and as the founder of the open-access journal Novelty in Psychology. He has published extensively, including 12 Web of Science (Q1) and 21 Scopus-indexed works, and serves on the editorial boards of 24 international journals. With over 670 manuscript reviews listed on ORCID, he has received multiple awards recognizing his scientific contributions. Dr. Uludag also manages four ongoing book projects. Skilled in Python-based machine learning and data analysis tools, he is eager to collaborate on innovative research that contributes meaningfully to psychology and society.

Profile

Education 🎓

Dr. Uludag earned his Ph.D. in Applied Psychology from the University of Chinese Academy of Sciences (2019–2023, GPA 3.93), focusing on brain imaging and mental health. He completed an M.A. in Forensic Sciences (Social Sciences) from Istanbul University (2016–2018, GPA 3.61), where he developed a strong foundation in psychological evaluation in legal settings. His undergraduate degree in Psychological Counseling and Guidance was obtained from Çanakkale Onsekiz Mart University (2012–2016, GPA 3.30), complemented by an associate degree in Laboratory Assistant and Veterinary Sciences from Eskisehir Anatolian University (2013–2015, GPA 3.79). He has also pursued training in TESOL, SPSS, machine learning (random forest, SVM, logistic regression, neural networks), Python programming, web development, and data visualization. His education has been guided by distinguished scholars including Prof. Xiang Yang Zhang, Prof. Erdinc Ozturk, and Prof. Neylan Ziyal. These experiences shaped his multidisciplinary approach to psychological research.

Experience 👨‍🏫

Dr. Kadir Uludag is currently a postdoctoral researcher at Shanghai Jiao Tong University (2023–Present) and has been appointed for a future role at Capital Medical University, Beijing (2025–). His expertise spans schizophrenia, neuroimaging, and educational psychology. Previously, he served as a special education teacher for autistic children at Karabük Municipality Autistic Children Education Center (2017), applying cognitive-behavioral and humanistic therapeutic approaches. He also completed internships as a psychological counselor at Toki Anadolu Lisesi (2016) and a veterinary technician at Safranbolu Veterinary Clinic (2015). He brings in-depth knowledge of psychological development and intervention techniques across diverse settings. In academia, Dr. Uludag serves on the editorial boards of 24 journals and has edited four book projects. His dynamic involvement in teaching, research, editing, and mentoring reflects a holistic commitment to the field of psychology and science communication.

Awards & Recognitions 🏅

Dr. Uludag has received numerous accolades, including the “Highest Number of Views” award (2023–2024) from the Journal of Clinical and Basic Psychosomatics for his narrative review on smoking and schizophrenia. He earned reviewer awards from Imeta Journal and Imetaomics for reviewing more than five papers each. Additionally, he holds a Certificate of Excellence from the Shanghai Table Tennis Museum and the American Chemical Society Reviewer Lab Certificate. His extensive peer-review contributions (over 670 reviews) are recognized by ORCID and editorial teams worldwide. His editorial involvement includes serving on boards of journals like Health Policy and Technology, Plos One, and Asean Journal of Psychiatry, among others. He has received invitations for guest editorships and honorary memberships in various scholarly outlets. These honors reflect his impactful presence in academia and his dedication to advancing global psychological research.

Research Interests 🔬

Dr. Kadir Uludag’s primary research interests include schizophrenia, neuroimaging (fMRI and EEG), and educational psychology. His doctoral work applied Python-based machine learning (random forest, SVM, logistic regression) to brain imaging data, emphasizing computational psychiatry and precision diagnostics. He has published in Q1 journals such as Asian Journal of Psychiatry, American Chemical Neuroscience, Psychology Research and Behavior Management, General Psychiatry, and Antioxidants. His Scopus-indexed contributions span educational psychology, forensic science, and neuroscience. His research applies interdisciplinary tools—Python, Psychopy, SPSS, R, NLP, and image processing libraries—to explore psychiatric conditions. He integrates theory and practice through data visualization, cognitive-behavioral therapy models, and open-science advocacy. Dr. Uludag actively shares findings via his YouTube channel and academic website, fostering transparency and education. His work aims to bridge gaps between neuroscience, education, and technology to improve mental health outcomes and knowledge dissemination.

Publications

Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Vahid Rashedi | Alzheimer’s disease | Best Researcher Award

Dr. Vahid Rashedi 👨‍⚕️, an esteemed Assistant Professor of Gerontology at the University of Social Welfare and Rehabilitation Sciences 🇮🇷, has made outstanding global contributions in aging, cognition, and psychogeriatrics 🌍🧠. With a Ph.D. in Gerontology (2017) 🎓 and extensive editorial duties across high-impact journals 📚, he’s actively involved as a Senior Collaborator with the Global Burden of Disease Project at IHME, University of Washington 🇺🇸. Recognized as a Top 1% scientist by Stanford University in 2024 🏅, he combines academic excellence, innovation, and impactful research. His interdisciplinary work spans gerontology, rehabilitation, mental health, and cognitive science, cementing his status as a global leader in aging research 🌐💡.

Profile

Education 🎓

Dr. Rashedi began his academic path with a Bachelor’s and Master’s degree in Rehabilitation Sciences 🎓🦾, focusing on geriatric care and assistive technology. He earned his Ph.D. in Gerontology with distinction in 2017 🥇, building expertise in psychogeriatrics, mental health, and cognitive decline. His academic training was rooted in interdisciplinary frameworks linking medicine, psychology, and social work 🔬💬. This diverse education empowered him to bridge clinical insights with research, enabling innovative health solutions for elderly populations 👵👴. He complements formal education with global scientific memberships and ongoing collaborations with prestigious institutes, such as IHME 🌎, emphasizing lifelong learning and cutting-edge research.

Experience 👨‍🏫

Dr. Rashedi has over a decade of rich academic and research experience, currently serving as Assistant Professor at the University of Social Welfare and Rehabilitation Sciences 🏫. Since 2019, he has been a Senior Collaborator at IHME, University of Washington, contributing to the Global Burden of Disease project 📊🌐. He has authored 126 indexed journal articles 📑, published a book 📖, and holds four patents, including rehabilitation innovations like the vibrating ankle-foot orthosis 🦿. He is a prolific editorial board member and associate editor for over 10 international journals 📘🖋️. His work in psychogeriatrics and cognition has garnered global recognition, highlighting his leadership and mentoring roles 👨‍🏫🏅.

Awards & Recognitions 🏅

Dr. Rashedi is recognized globally for his scientific excellence, notably ranked in the Top 1% of scientists worldwide by Stanford University in 2024 🌟📈. He holds editorial roles in Frontiers, CGJ, and the Journal of Gerontology, reflecting scholarly esteem 📚. He is a trusted reviewer for numerous high-impact journals and was honored with national and international awards 🥇. His patented inventions in geriatric rehabilitation demonstrate a blend of innovation and clinical value 💡🏥. His GSA, APA, and ISTAART memberships validate his international standing 👏🌐. These honors underscore his unwavering dedication to improving elderly lives through evidence-based science and collaboration 🤝

Research Interests 🔬

Dr. Rashedi’s research delves into psychogeriatrics, mental health, and cognitive disorders in aging populations 🧠👴. As part of the Global Burden of Disease team at IHME 🌍, he contributes to global health analytics, shaping international aging policies 📊. His innovations include assistive devices with therapeutic functions, bridging technology and clinical rehabilitation 🛠️⚙️. With 63 research projects and over 26,000 citations 🔍📈, his scholarly output is extensive and impactful. He leads investigations on dementia, geriatric depression, and cognitive resilience, supported by his roles in editorial boards and scientific societies 🧬📘. His mission is to translate research into real-world health solutions for aging communities 🌟🩺.

Publications 

Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Published on by Cognitive Scientist Awards

Prof Dr. Aynur Müdüroğlu Kırmızıbekmez | Neurodevelopmental Disorders | Best Researcher Award

Asst. Prof. Aynur Müdüroğlu Kırmızıbekmez is a neuroscientist at İstanbul Nişantaşı University, specializing in neurodegenerative diseases, neuroprotection, and the gut-brain axis. She completed her Ph.D. in Neuroscience at Istanbul University in 2013 and has been a faculty member since 2014. Her research spans Alzheimer’s, autism, and Parkinson’s disease, focusing on stem cell therapies and functional foods for cognitive enhancement. She has led TÜSEB-approved projects and holds patents on bioactive functional foods. Aynur teaches Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She actively contributes to cutting-edge innovations, particularly in prebiotic-microbiota interactions.

Profile

Education 🎓

Aynur Müdüroğlu Kırmızıbekmez earned her Ph.D. in Neuroscience from Istanbul University in 2013. Her academic journey emphasized neurobiology, neurodegenerative disease mechanisms, and innovative therapeutic strategies. Her doctoral research focused on neuroprotective compounds in Alzheimer’s disease. Before her Ph.D., she pursued studies in molecular biology and biotechnology, refining her expertise in cellular neuroscience. Throughout her education, she collaborated on interdisciplinary projects, integrating neurophysiology with pharmacological advancements. Her postdoctoral research extended into translational neuroscience, bridging laboratory findings with clinical applications. Aynur’s academic foundation laid the groundwork for her extensive research on cognitive function, stem cell therapy, and the gut-brain axis.

Experience 👨‍🏫

With over a decade of experience, Aynur Müdüroğlu Kırmızıbekmez has been an Assistant Professor at İstanbul Nişantaşı University since 2014. She has led multiple national and international neuroscience projects, including TÜSEB-approved research on Parkinson’s and Alzheimer’s diseases. Aynur has played a pivotal role in developing functional foods aimed at cognitive enhancement and has secured patents for novel bioactive compounds. She actively collaborates with industry and academia, integrating neuroscience with biotechnology. Her teaching portfolio includes Neurology, Cognitive Neurophysiology, and Industrial Biotechnology. She has also mentored numerous graduate students in neuropharmacology and neurodegenerative research.

Research Interests 🔬

Aynur Müdüroğlu Kırmızıbekmez’s research focuses on neurodegenerative diseases, neuroprotection, and the gut-brain axis. She explores innovative therapies for Alzheimer’s, Parkinson’s, and autism, with a strong emphasis on stem cell applications. Her work investigates the neuroprotective potential of bioactive compounds and functional foods, aiming to enhance cognitive function. She has pioneered research on the microbiota-brain relationship, particularly the role of prebiotics in neurodegeneration. Aynur’s projects also include SNP-based qPCR diagnostic tools for Alzheimer’s risk assessment. Through interdisciplinary collaborations, she integrates neuroscience with biotechnology, advancing the understanding of cognitive disorders and potential therapeutic interventions.

Awards & Recognitions 🏅

Aynur Müdüroğlu Kırmızıbekmez has received multiple awards for her contributions to neuroscience, including national research grants and innovation awards for her work on functional foods for neuroprotection. She was honored by TÜSEB for her groundbreaking research in stem cell therapy for Parkinson’s disease. Her patented functional chocolate enriched with bioactive compounds received recognition for its cognitive benefits. Aynur has also been awarded project grants from TÜBİTAK for her research on neurodegeneration. She has been invited as a keynote speaker at international neuroscience conferences and has been recognized for her contributions to cognitive science.

Publications 📚

  • Attila Altunel, Aynur Muduroglu-Kirmizibekmez, Alparslan Onder, Ozlem Altunel, Ali
    Sever, Ihsan Kara, Efficacy of ACTH therapy in children with Landau-Kleffner Syndrome
    and Autism Spectrum Disorder: A retrospective analysis, Epilepsy & Behavior,Vol
    165,2025,110308, https://doi.org/10.1016/j.yebeh.2025.11030
  • Muduroglu-Kirmizibekmez A, Cati C, Onder A, Aydin S, Kara I. Investigation of the acute
    impact of rosemary consumption on brain activity in healthy volunteers. Nutr
    Neurosci. 2024 Jul 6:1-12. doi: 10.1080/1028415X.2024.2370729. Epub ahead of print.
    PMID: 38970803.
  • Biliz Y, Hasdemir B, Başpınar Küçük H, Zaim M, Şentürk AM, Müdüroğlu Kırmızıbekmez
    A, Kara İ. Novel N-Acyl Hydrazone Compounds as Promising Anticancer Agents:
    Synthesis and Molecular Docking Studies. ACS Omega. 2023 May 20;8(22):20073-
    20084. doi: 10.1021/acsomega.3c02361. PMID: 37305237; PMCID: PMC10249086.
  • Aydin S, Erözden AA, Tavşanlı N, Müdüroğlu A, Çalışkan M, Kara İ. Anthocyanin
    Addition to Kefir: Metagenomic Analysis of Microbial Community Structure. Curr
    Microbiol. 2022 Sep 20;79(11):327. doi: 10.1007/s00284-022-03017-x. PMID:
    36125585
  • Altunel Atilla, Müdüroğlu Kirmizibekmez Aynur, Altunel Emine Özlem (2022).
    Hypsarrhythmia Paroxysm Intensities that Initiate and Render Physical & Mental
    Retardation Irreversible in West Syndrome. International Journal of Neuroscience,
    DOI: 10.1080/00207454.2022.2078208 (Publication No: 7685958)

Grit Hein | Social Neuroscience | Best Paper Award

Published on by Cognitive Scientist Awards

prof. Grit Hein | Social Neuroscience | Best Paper Award

 

Universität Würzburg, Germany

Profile

Education

She studied Psychology at Humboldt-University in Berlin, Germany, and City College in New York, USA, completing her diploma in 1999 with a grade of “very good.” She earned her doctorate in 2002 at the Max-Planck-Institute for Human Cognitive and Brain Sciences in Leipzig and Humboldt-University in Berlin. Her academic and professional career progressed through various prestigious positions. In 2002, she began as a research associate at MRC Cambridge, UK, and the University Hospital Frankfurt/M. She then received a DFG-Research Stipend in 2006, conducting research at the Helen Wills Neuroscience Institute, University of Berkeley, USA. In 2008, she was awarded the Society-in-Science Stipend and became a Principal Investigator in an independent research project at the University of Zürich, Switzerland. She completed her habilitation and obtained her Venia Legendi in Psychology at Goethe-University Frankfurt/M. in 2014. She later served as a Senior Lecturer at the University of Bern, Switzerland, in 2015. In 2017, she was appointed as a Heisenberg Professor at JMU Würzburg, where she continued to advance her research. In 2021, she became a Professor of Translational Social Neuroscience at JMU Würzburg and a Steering Committee Member of the Research Training Group RTG 2660, working alongside Professor Dr. Matthias Gamer in Psychology.

Work experience

Since 2024, she has served as the President of the European Social and Affective Neuroscience Association (ESCAN) – Special Interest Group Social Neuroscience and as the spokesperson for the Neuroscience section at the Graduate School of Life Sciences (GSLS), JMU. Previously, from 2021 to 2024, she held the position of Vice President of ESCAN. Since 2022, she has been a board member of the China-Competence Center at JMU, and since 2021, she has been an Executive Board and Steering Committee Member of the Research Training Group RTG 2660. Her engagement in the research system extends further, as she has been a board member of ESCAN since 2019 and a member of the mentoring program for young female scientists at UKW, JMU. Additionally, she holds a double affiliation with both the Medical Faculty and the Faculty of Human Science at JMU. Since 2018, she has contributed as a panel member of the Hillary Green Research Fund at the University of Birmingham, a standing member of the dissertation committee at UKW, JMU, and a member of the Degree Subject Committee of the Elite Graduate Program in Translational Neuroscience at JMU. She has also supervised numerous early-career researchers, including Anne Saulin, who completed her PhD in 2023 with magna cum laude and is now a DFG postdoctoral fellow at the University of Birmingham, UK; Marthe Gründahl, who also earned her PhD in 2023 with magna cum laude and is now a consultant at Bain & Company; and Dorothee Bruch, who obtained her MD in 2022 with magna cum laude and is currently practicing as a gynecologist.

She has received several prestigious academic distinctions throughout her career. In 2023, she was honored with an award for her extraordinary contribution to teaching by the Medical Faculty and the President of JMU. In 2015, she was awarded the Heisenberg Fellowship by the German Research Foundation, recognizing her outstanding research achievements. Earlier in her career, she received the Branco-Weiss Fellowship from ETH Zürich in 2008 and the Emmy-Noether Fellowship from the German Research Foundation in 2005, both of which supported her innovative research endeavors.

Publication

Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Arunachalam Muthuraman | Cognitive Neuroscience | Best Researcher Award 🏆

Information Technology at   Duhok Polytechnic University🎓

Dr. Arunachalam Muthuraman is an Associate Professor in the Pharmacology Unit at AIMST University, Malaysia, with over 13 years of experience in pharmaceutical sciences. He holds an M. Pharm in Pharmacology and a Ph.D. in Neuropharmacology from Punjabi University, India. His research focuses on renal pharmacology, neuropharmacology, toxicology, cancer cell biology, and herbal technology. Dr. Muthuraman has published 84 research papers, 18 review articles, and authored multiple book chapters. His work has earned him prestigious recognitions, including the Elsevier Top 2% Scientist Rank in 2024 and the Global Top-50 Academician Award in 2023. He has guided numerous students, including Ph.D. candidates, and has contributed significantly to international conferences and workshops. Dr. Muthuraman is passionate about advancing pharmaceutical science and nurturing future researchers.

Professional Profile 

Education 🎓:

Dr. Arunachalam Muthuraman holds a Bachelor of Pharmacy (B.Pharm) from The Tamilnadu Dr. MGR Medical University (2001-2005), a Master of Pharmacy (M.Pharm) in Pharmacology from Punjabi University (2005-2008), and a Ph.D. in Neuropharmacology from the same university (2008-2012). His academic foundation laid a strong base for his deep dive into pharmacology, particularly in neuropharmacology, renal pharmacology, and toxicology.

Work Experience 💼:

With over 13 years of academic experience, Dr. Muthuraman is currently an Associate Professor at AIMST University, Malaysia (2023-present), specializing in pharmacology. He has also held positions as Assistant Professor and Senior Lecturer in the Pharmacology Unit at AIMST University, demonstrating significant leadership and contributions to pharmacology education. Prior to this, he worked as an Associate Professor and Head of the Akal Pharmacology & Toxicology Research Centre at Akal College of Pharmacy, India.

Skills 🔍

Dr. Muthuraman is skilled in diverse areas of pharmacology, including renal pharmacology, neuropharmacology, toxicology, and cancer cell biology. His expertise spans cellular and molecular pharmacology, cardiovascular pharmacology, and herbal technology, with a focus on drug research and development, clinical pharmacology, and technology-enhanced therapeutic solutions.

Awards and Honors 🏆

Dr. Muthuraman has received prestigious recognitions, such as Elsevier’s Top 2% Scientist Rank in 2024, acknowledging his high impact research publications. He was also named in the Global Top-50 Academicians & Researchers of 2023 for his outstanding contributions to pharmaceutical sciences. Additionally, he was awarded the International Achievement Award in 2023 for his research contributions in pharmaceutical science.

🤝 Memberships:

Dr. Muthuraman is actively involved in several international scientific communities and academic organizations, reflecting his dedication to advancing pharmaceutical research and education.

Teaching Experience 👩‍🏫:

As a passionate educator, Dr. Muthuraman has guided numerous students at the Ph.D., M.Pharm, and B.Pharm levels. He has supervised 9 Ph.D. students, 25 M.Pharm students, and 39 B.Pharm students, contributing to the academic and professional growth of his students. His teaching focuses on imparting knowledge in pharmacology, toxicology, and drug research.

Research Focus 🔬:

Dr. Muthuraman’s research is primarily focused on neuropharmacology, renal pharmacology, and toxicology, with an emphasis on discovering novel drug therapies for chronic diseases and cancer. His research on cellular & molecular pharmacology and the integration of herbal technology in drug development is also pioneering. He has published 84 research papers, authored 2 books, and contributed to numerous book chapters, demonstrating his leadership in academic research.

Conclusion 

Dr. Arunachalam Muthuraman is an outstanding candidate for the Best Researcher Award, with his exceptional track record in pharmaceutical sciences, his contributions to advancing pharmacological research, and his commitment to mentoring future scholars. His continuous drive for excellence and innovative approach to research makes him a deserving recipient of this prestigious award.

📚 Publilcation

    1. Therapeutic investigation of beta-carotene on diabetic retinopathy associated Alzheimer’s disease progression via the regulation of reactive glial cell functions in diabetic mice
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: Y Paramaswaran, A Muthuraman
    2. Beta-carotene ameliorates vascular dementia via modulation of homocysteine and endothelial nitric oxide synthase expression in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: KG Lim, A Muthuraman
    3. Therapeutic potential of beta-carotene on intracisternal injection of glucose oxidase-induced senile dementia in diabetic rats
      • Year: 2024
      • Journal: Alzheimer’s Association International Conference
      • Authors: A Muthuraman, KG Lim
    4. Traditional Therapies Involving Nutrition for the Management of COVID-19
      • Year: 2024
      • Journal: Coronaviruses 5 (2), 40-48
      • Authors: R Muthusamy, A Muthuraman, K Anand
    5. NEUROBEHAVIORAL AND NEUROCHEMICAL EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) INHIBITOR–GEFITINIB IN Β-AMYLOID OLIGOMER INDUCED ALZHEIMER’S DISEASE IN MICE MODEL
      • Year: 2024
      • Journal: Journal of Digital Economy 3 (1), 1-12
      • Authors: J Dhamodharan, G Sekhar, A Muthuraman
    6. Ameliorative potential of Astaxanthin on glyphosate-induced neurocognitive functional changes in adult zebrafish via acid phosphatase and annexin A2 dysfunction
      • Year: 2024
      • Journal: World 6 (01), 008-019
      • Authors: KZ Xuan, N Perveen, NH Khan, A Muthuraman
    7. Ameliorative potential of thymoquinone in four vessel occlusion induced vascular dementia in rats
      • Year: 2023
      • Journal: Alzheimer’s & Dementia 19, e071053
      • Authors: N Rishitha, A Muthuraman
    8. Preventive Action of Beta-Carotene against the Indoxyl Sulfate-Induced Renal Dysfunction in Male Adult Zebrafish via Regulations of Mitochondrial Inflammatory and β-Carotene
      • Year: 2023
      • Journal: Biomedicines 11 (10), 2654
      • Authors: A Muthuraman, ASM Sayem, S Meenakshisundaram, N Ali, SF Ahmad, et al.